🔎 Trials Near Me

Home › Opioid Overdose › South Carolina › Charleston

Opioid Overdose clinical trials in Charleston, SC

6 studies for Opioid Overdose are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD

Recruiting
  • Medical University of South Carolina, Charleston
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06157840

Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine

Recruiting
  • Medical University of South Carolina, Charleston
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07278518

Social Functioning in Opioid Use Disorder

RecruitingHealthy volunteers welcome
  • Medical University of South Carolina, Charleston
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07044466

Pilot of Mailing Buprenorphine

RecruitingEarly phase 1
  • Medical University of South Carolina, Charleston
  • Medical University of South Carolina, Charleston
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07421102

Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons

Recruiting
  • Medical University of South Carolina, Charleston
Ages 18 to 45 · Women · Updated Apr 8, 2026 · NCT06999811

Integrated Treatment for Opioid Use Disorder and PTSD

Recruiting
  • Medical University of South Carolina, Charleston
Ages 18 to 70 · All sexes · Updated Nov 28, 2025 · NCT06641115

About Opioid Overdose

Opioid overdose leads to slowing or stopping of breathing and sometimes death. You can take steps to help prevent an overdose, and respond to one with naloxone.

More about Opioid Overdose on MedlinePlus

Opioid Overdose trials in other cities

Other studies in Charleston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.